Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Takako Yanai Takahashi"'
Autor:
Hirotoshi Iihara, Mototsugu Shimokawa, Masakazu Abe, Mitsue Saito, Toru Mukohara, Hironobu Hashimoto, Rie Ozeki, Hiroko Bando, Toshinobu Hayashi, Hitoshi Kawazoe, Masayo Komoda, Takako Yanai Takahashi
Publikováno v:
BMJ Open, Vol 12, Iss 3 (2022)
Introduction Triple antiemetic therapy with neurokinin-1 receptor antagonist, 5-hydroxytryptamine type 3 receptor antagonist, and dexamethasone has been widely recommended for high emetogenic chemotherapeutic (HEC) agents and regimens, including anth
Externí odkaz:
https://doaj.org/article/43e5a77aedcb4def83629d8a622a26e8
Autor:
Masakazu Abe, Takuhiro Yamaguchi, Yukiyoshi Fujita, Tomoyasu Nishimura, Koichi Kitagawa, Naoki Inui, Katsuya Hirano, Yukio Sakata, Hirotoshi Iihara, Yuichi Shibuya, Kenichi Suzuki, Kazuhiko Shibata, Kensuke Hori, Haruko Daga, Toshiaki Nakayama, Yasuhiko Sakata, Takako Yanai Takahashi, Sadamoto Zenda, Hironobu Hashimoto
Publikováno v:
JAMA Network Open. 6:e2310894
ImportanceIt is unknown whether olanzapine combined with triplet antemetic therapy is effective for all patients undergoing highly emetogenic chemotherapy. A secondary analysis of randomized clinical trials using olanzapine may provide insight into t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::49d9da4f5a66fcb0d5a4edbfe9aa255b
https://doi.org/10.1001/jamanetworkopen.2023.10894
https://doi.org/10.1001/jamanetworkopen.2023.10894
Autor:
Rie Ozeki, Hirotoshi Iihara, Mototsugu Shimokawa, Hironobu Hashimoto, Masakazu Abe, Toru Mukohara, Hiroko Bando, Toshinobu Hayashi, Hitoshi Kawazoe, Masayo Komoda, Takako Yanai Takahashi, Mitsue Saito
Publikováno v:
BMJ open. 12(3)
IntroductionTriple antiemetic therapy with neurokinin-1 receptor antagonist, 5-hydroxytryptamine type 3 receptor antagonist, and dexamethasone has been widely recommended for high emetogenic chemotherapeutic (HEC) agents and regimens, including anthr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f29c9c1aa5b0ae46dc8ed3021eecd0b
https://pubmed.ncbi.nlm.nih.gov/35236735
https://pubmed.ncbi.nlm.nih.gov/35236735
Autor:
Masakazu Abe, Yuichiro Ohe, Osamu Tokuyama, Hideaki Mizutani, Michiru Sakurai, Koki Mizukami, Daisuke Takei, Kazuhisa Nakashima, Yukari Hoshina, Hironobu Hashimoto, Takuhiro Yamaguchi, Noboru Yamamoto, Yasuhiko Sakata, Masahiko Nakao, Takako Yanai Takahashi, Sadamoto Zenda, Satoru Iwasa, Yosuke Uchitomi
Publikováno v:
The Lancet Oncology. 21:242-249
Summary Background Olanzapine 10 mg added to standard antiemetic therapy including aprepitant, palonosetron, and dexamethasone has been recommended for the prevention of chemotherapy-induced nausea and vomiting. Guidelines suggest that a dose reducti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1ca620a723224e35baee8d02b3d82dc1
https://doi.org/10.1016/s1470-2045(19)30678-3
https://doi.org/10.1016/s1470-2045(19)30678-3
Autor:
Hironobu, Hashimoto, Satoru, Iwasa, Takako, Yanai-Takahashi, Yoshitaka, Honma, Ken, Kato, Tetsuya, Hamaguchi, Yasuhide, Yamada, Yasuhiro, Shimada, Naoya, Yamazaki, Yasuhisa, Kato
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 47(6)
Skin toxicities associated with anti-epidermal growth factor receptor(EGFR)antibodies, have a profound effect on the continuation of treatment. We assessed the efficacy and safety of vitamin K1(VK1)ointment for acneiform eruptions induced by anti-EGF
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c74edff839ab55020bb784e3bb320ec9
https://pubmed.ncbi.nlm.nih.gov/32541171
https://pubmed.ncbi.nlm.nih.gov/32541171